A nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle

Details for Australian Patent Application No. 2006280519 (hide)

Owner Genovis AB

Inventors Fredriksson, Sarah; Toftevall, HannaKarin; Olsson, Fredrik; Koivunen, Sylvia

Agent Davies Collison Cave

Pub. Number AU-B-2006280519

PCT Pub. Number WO2007/021236

Priority 60/709,454 19.08.05 US

Filing date 21 August 2006

Wipo publication date 22 February 2007

Acceptance publication date 16 June 2011

International Classifications

A61N 2/04 (2006.01) Magnetotherapy

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/021236 Priority application(s): WO2007/021236

16 June 2011 Application Accepted

  Published as AU-B-2006280519

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006280527-Electrolyte comprising eutectic mixture and electrochemical device using the same

2006280518-Method for production of layered substrates